Back | Next |
home / stock / blrx / blrx message board
Subject | By | Source | When |
---|---|---|---|
The gaining last trade up | midastouch017 | investorshub | 04/22/2023 8:55:54 PM |
$BLRX The now up | midastouch017 | investorshub | 04/20/2023 2:14:26 PM |
$BLRX Price trading | midastouch017 | investorshub | 04/19/2023 11:49:41 AM |
$BLRX MomentumIts trading last up | midastouch017 | investorshub | 04/19/2023 1:47:29 AM |
I have been in $BLRX since 2019. | midastouch017 | investorshub | 04/18/2023 4:10:29 PM |
$BLRX has a new National Sales Director | jcon777 | investorshub | 04/18/2023 3:15:24 PM |
Welcome Spidey. | jcon777 | investorshub | 04/18/2023 3:08:29 PM |
Adding Aphexda helps to collect more stem cells | midastouch017 | investorshub | 04/18/2023 5:21:50 AM |
Excellent news and sp remains stagnant? | midastouch017 | investorshub | 04/17/2023 4:20:39 PM |
BioLineRx Announces Publication in Nature Medicine of its | midastouch017 | investorshub | 04/17/2023 3:51:03 PM |
Additionally, given they are above the 1USD price | midastouch017 | investorshub | 04/13/2023 4:54:59 PM |
BioLineRx Medical Affairs Team at ASFA Congress | midastouch017 | investorshub | 04/13/2023 4:52:13 PM |
1.1400+0.0800 (+7.55%) | midastouch017 | investorshub | 04/11/2023 3:49:31 PM |
I haven't put in a large sum | midastouch017 | investorshub | 04/11/2023 5:44:00 AM |
Indeed, I was looking to get to May 1st | Spideyboy | investorshub | 04/11/2023 5:31:56 AM |
Today will be day 2 of 10. | midastouch017 | investorshub | 04/11/2023 5:15:52 AM |
Just joined the party. | midastouch017 | investorshub | 04/11/2023 5:12:26 AM |
Heck, I don't know what's going on with | Spideyboy | investorshub | 04/11/2023 3:57:05 AM |
Day 1 of 10 | BarrellofHay | investorshub | 04/10/2023 7:52:56 PM |
BioLine RX ($BLRX) | midastouch017 | investorshub | 04/10/2023 9:16:17 AM |
News, Short Squeeze, Breakout and More Instantly...
BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD) PR Newswire - Investigator-initiated study in...
Orkla ASA ADR (ORKLY) is expected to report for Q1 2024 Cosmos Health Inc. (COSM) is expected to report $-0.14 for Q1 2024 Basilea Pharmaceutica AG Registered Shares (BPMUF) is expected to report for Q1 2024 DCC Plc (DCCPF) is expected to report for Q4 2024 Datatec Ltd ADR (DTTLY)...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting PR Newswire New analysis of biopsy samples demonstrate...